ライフサイエンスにおける量子センシングの可能性
弊社は量子センシング技術のリーダーであるスイスのQnami社から、バイオメディカル分野においてNV磁力計が臨床的価値を提供し、新たなビジネスを生み出す可能性のあるアプリケーションを特定するよう依頼されました。
弊社は量子センシング技術のリーダーであるスイスのQnami社から、バイオメディカル分野においてNV磁力計が臨床的価値を提供し、新たなビジネスを生み出す可能性のあるアプリケーションを特定するよう依頼されました。
The proposal estimates compliance costs at €29 billion but could provide cyber-clarity.
Lizzie Thomas presents her case for designing improved, sustainable drug delivery product design. Currently, the approach is dominated at the outset by patient-centricity. This focus means that wider, more long-term implications simply aren’t considered early enough.
Rodney Richardson, software and systems engineer, who has spent the past 20 years designing and developing medical software, outlines ten essential points for medical device developers regarding cybersecurity.
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong.